Search
moon
sun

T147. Diabetes in children

โ… . DKA (diabetic ketoacidosis)
1.
Metaboic acidosis (pH <7.30 or serum bicarbonate level of <15 mEq/L) with hyperglycemia (Serum glucose level of >200 milligrams/dL [>11 mmol/L]) and ketonemia ๋กœ ์ •์˜
2.
์†Œ์•„ DKA ํ™˜์ž์—์„œ ์˜์‹ ์ €ํ•˜๊ฐ€ ๋™๋ฐ˜๋˜๋Š” ๊ฒฝ์šฐ cerebral edema ๋ฐœ์ƒ ๊ฐ€๋Šฅ์„ฑ์„ ๊ณ ๋ ค
3.
๋‹น๋‡จ๋ฅผ ์ง„๋‹จ๋ฐ›์€ ์  ์—†๋Š” ์ฒญ์†Œ๋…„ ํ™˜์ž์—์„œ ํ˜ˆ๋‹น์€ ์ •์ƒ์ธ๋ฐ, ketoacidosis๊ฐ€ ์žˆ๋Š” ๊ฒฝ์šฐ ์—ํ‹ธ๋ Œ๊ธ€๋ฆฌ์ฝœ, ์ด์†Œํ”„๋ฆด ์•Œ์ฝœ, salicylate ์ค‘๋…์„ ๊ณ ๋ ค
4.
๊ฒ€์‚ฌ (1) VBGA์˜ pH๋Š” ABGA์— ๋น„ํ•ด 0.03 ๋‚ฎ์Œ - ์‚ฐ-์—ผ๊ธฐ ์ƒํƒœ๋ฅผ ์ž˜ ๋ฐ˜์˜ํ•œ๋‹ค. (2) ๊ฒ€์‚ฌ ๋ฐฉ๋ฒ•์— ๋”ฐ๋ผ acetoacetate์€ serum creatinine level ์ด ๋†’์€ ๊ฒƒ์ฒ˜๋Ÿผ ๋ณด์ด๊ฒŒ ํ•  ์ˆ˜ ์žˆ์Œ. ฮฒ-hydroxybutyrate๋Š” creatinine level์„ ์˜ฌ๋ฆฌ์ง€ ์•Š์Œ (3) ๋Œ€๊ฒŒ ํ˜ˆ๋‹น์€ 350>mg/dL์ด๋‚˜, 300 ๋ฏธ๋งŒ๋„ ๊ฐ€๋Šฅ, ์ฒญ์†Œ๋…„๊ธฐ์—์„œ๋Š” ๊ตฌํ† ๊ฐ€ ์‹ฌํ•˜๊ฑฐ๋‚˜ ์˜ค๋ž˜ ๊ตถ์€ ๊ฒฝ์šฐ euglycemic DKA ๋„ ๊ฐ€๋Šฅํ•จ. ์ด ๊ฒฝ์šฐ์—๋„ ์ธ์А๋ฆฐ ์‚ฌ์šฉ์€ ํ•„์š”ํ•จ
5.
์น˜๋ฃŒ
โ€ข
Cardiac monitoring ํฌํ•จํ•œ intensive monitoring ํ•„์š”ํ•จ.
โ€ข
QT prolongation์ด ketosis์™€ ํ•จ๊ป˜ ์ž˜ ๋ฐœ์ƒ.
โ€ข
Perfusion, electrolyte disturbance, mental status, ketonemia์— ์œ ์˜
(1) Fluid resuscitation โ‘  ๋Œ€๊ฒŒ fluid deficit์€ ๋ชธ๋ฌด๊ฒŒ์˜ 5~10%์ž„. โ‘ก Shock state์ธ ๊ฒฝ์šฐ 20ml/kg์˜ NS๋ฅผ bolus ํˆฌ์—ฌ. โ‘ข Shock ์ง€์† ์‹œ ๋ฐ˜๋ณต ํˆฌ์—ฌ ๊ฐ€๋Šฅ. โ‘ฃ Shock์—์„œ ํšŒ๋ณต๋˜๋ฉด fluid deficit์„ ๋„ˆ๋ฌด ๋นจ๋ฆฌ ๊ต์ •ํ•˜๋Š” ๊ฒƒ์€ ์ง€์–‘ (ํŠนํžˆ osmolality>340mOsml/L) โ‘ค 24~48์‹œ๊ฐ„ ๋™์•ˆ ๊ต์ •ํ•ด์ฃผ๊ธธ ๊ถŒ์œ ํ•จ. : ์ „ํ†ต์ ์ธ ๋ฐฉ์‹์€ ์ฒ˜์Œ 8์‹œ๊ฐ„ ๋™์•ˆ fluid deficit์˜ ์ ˆ๋ฐ˜ ๊ต์ • โ†’ ์ดํ›„ 16์‹œ๊ฐ„ ๋™์•ˆ ๋‚˜๋จธ์ง€ ์ ˆ๋ฐ˜ ๊ต์ •
(2) ์ „ํ•ด์งˆ ์ด์ƒ โ‘  Sodium level์˜ ๊ต์ • ์‹คํŒจ๋Š” ๋‡Œ๋ถ€์ข…์˜ ๋ฐœ์ƒ๊ณผ ์—ฐ๊ด€ โ‘ก ์นผ๋ฅจ์€ hyperkalemia๊ฐ€ ๋ฐฐ์ œ๋˜๊ณ  ์†Œ๋ณ€์ด ๋‚˜์˜ค๋Š” ๊ฒƒ์ด ํ™•์ธ๋˜๊ธฐ ์ „์—๋Š” ํˆฌ์—ฌํ•˜๋ฉด ์•ˆ ๋œ๋‹ค. : ์นผ๋ฅจ ์ˆ˜์น˜๋Š” ๋ชจ๋‹ˆํ„ฐ๋ง ํ•„์š”ํ•˜๋ฉฐ, ์ˆ˜์•ก ๋ฐ ์ธ์А๋ฆฐ ์น˜๋ฃŒ ์‹œ ๊ฐ์†Œํ•œ๋‹ค. : ์ดˆ๊ธฐ๋ถ€ํ„ฐ hypokalemia๊ฐ€ ์žˆ๋Š” ๊ฒฝ์šฐ์—๋Š” ์ ๊ทน์ ์ธ replace๊ฐ€ ํ•„์š”ํ•จ. : Potassium replacement ๋ฐฉ๋ฒ•์€ ๋‹ค์–‘ํ•˜๋‚˜, ๋ณดํ†ต 30~40mEq/L์˜ ํฌํƒ€์Š˜์„ ์œ ์ง€ ์ˆ˜์•ก์— ํฌํ•จํ•ด์•ผ ํ•จ โ‘ข Phosphate, Magnesium, hypocalcemia ๋Š” ์ •๋ฆฝ๋œ ๊ฒƒ ์—†์Œ. ๋ถ€์กฑํ•˜๋ฉด ๊ทธ ๋•Œ, ๊ทธ ๋•Œ ๋ณด์ถฉ. (3) ์ธ์А๋ฆฐ โ‘  0.1unit/kg/hr๋กœ ํˆฌ์—ฌ : Serum glucose 50~100mg/dL/hr(2.8~5.6mmol/L)์˜ ์†๋„๋กœ ๊ต์ • : ์‹œ๊ฐ„ ๋‹น pH ๊ต์ •์ด 0.03๋ณด๋‹ค ๋А๋ฆฐ ๊ฒฝ์šฐ doubling. โ‘ก ํ˜ˆ๋‹น์˜ ๊ต์ •์ด pH์˜ ๊ต์ •๋ณด๋‹ค ๋น ๋ฆ„. : ํ˜ˆ๋‹น์ด 250mg/dL ๋ฐ‘์œผ๋กœ ๋–จ์–ด์ง€๋Š” ๊ฒฝ์šฐ ์ˆ˜์•ก์— ๋‹น ์ถ”๊ฐ€ : ํ˜ˆ๋‹น์„ 150~300mg/dL๋กœ ketoacidosis๊ฐ€ ํ˜ธ์ „๋  ๋•Œ๊นŒ์ง€ ์œ ์ง€ โ‘ข 0.1u/kg bolus ํˆฌ์—ฌ๋Š” cerebral edema๋ฅผ ์•…ํ™”์‹œํ‚ฌ ์ˆ˜ ์žˆ์–ด ๋” ์ด์ƒ ์ถ”์ฒœ๋˜์ง€ ์•Š์Œ โ‘ฃ SC insulin์œผ๋กœ ๋ณ€๊ฒฝํ•˜๋Š” ๊ฒฝ์šฐ์—๋„ 1~2์‹œ๊ฐ„ ๋™์•ˆ ์€ IV insulin์„ ์œ ์ง€ํ•˜์—ฌ์•ผ ํ•จ. โ‘ค Euglycemic DKA์˜ ๊ฒฝ์šฐ insulin๊ณผ ํ•จ๊ป˜ ๋‹น ์ˆ˜์•ก ํˆฌ์—ฌ.
: Glucose ๋†๋„๋ฅผ ์ตœ๋Œ€ํ•œ์œผ๋กœ ํ•˜์—ฌ ํˆฌ์—ฌํ•˜๋Š” ๊ฒฝ์šฐ 10~15๋ถ„ ๊ฐ€๋Ÿ‰ ์ธ์А๋ฆฐ์„ ์ค‘์ง€ ํ›„ ๊ฐ€์žฅ ๋‚ฎ์€ ์†๋„๋กœ ์‹œ์ž‘ํ•  ์ˆ˜ ์žˆ์Œ. ์ด ๊ฒฝ์šฐ์—๋„ 0.05units/kg/h๋ณด๋‹ค ๋นจ๋ผ์•ผ ํ•œ๋‹ค.
(4) Bicarbonate โ‘  Bicarbonate๋Š” pH<7.0์ด๋ฉด์„œ fluid resuscitation์— ๋ฐ˜์‘ํ•˜์ง€ ์•Š๋Š” ํ˜ˆ์•• ์ €ํ•˜๊ฐ€ ์žˆ๋Š” ๊ฒฝ์šฐ์— ํˆฌ์—ฌํ•˜๋Š” ๊ฒƒ์œผ๋กœ ์ œํ•œ. โ‘ก Correction ์€ pH 7.1 ๋ฐ serum bicarbonate level 10mEq/L์„ ๋„˜์ง€ ์•Š๋„๋ก ํ•จ.
โ…ก. Cerebral edema
1.
DKA ์†Œ์•„ ํ™˜์ž ์ค‘ 0.5~1%์—์„œ ๋ฐœ์ƒ. Risk factor๋Š” Table 147-2 ์ฐธ์กฐ.
2.
์ตœ๊ทผ ์—ฐ๊ตฌ๋“ค์€ overaggressive fluid resuscitation ๊ทธ ์ž์ฒด๊ฐ€ risk factor๋ผ๋Š” ์ฃผ์žฅ์— ๋Œ€ํ•ด ๋ฐ˜๋ฐ•.
3.
์ „์กฐ ์ฆ์ƒ์€ 50% ๋ฏธ๋งŒ์—์„œ ๋ฐœ์ƒ, ์‹ฌํ•œ ๋‘ํ†ต, ๊ฒฝ๋ จ, papilledema
4.์น˜๋ฃŒ (1) Mannitol (0.25 ~ 1g/kg IV bolus) ๋ฐ ํ•„์š” ์‹œ intubation (2) 3% saline 10ml/kg over 30min๋„ ๊ฐ€๋Šฅ.
โ…ข. Special considerations
1.
Insulin pump (1) ๋งŽ์€ DKA episode๋Š” pump ์˜ค์ž‘๋™์— ์˜ํ•จ. (2) ๊ธฐ๊ณ„๊ฐ€ ๊ณ ์žฅ์ด๋“  ์•„๋‹ˆ๋“ , ๊ธฐ๊ณ„๋Š” ๋„๊ณ  routine management๋ฅผ ํ•˜๋ฉด ๋œ๋‹ค.
2.
New-onset hyperglycemia (1) ์ดˆ๊ธฐ ์ธ์А๋ฆฐ ์šฉ๋Ÿ‰์€ 0.1unit/kg sc. (2) Daily insulin ์š”๊ตฌ๋Ÿ‰์€ ๋ณดํ†ต 0.5~1unit/kg/d๋ฅผ 2/3๋Š” ์•„์นจ์—, 1/3 ์˜คํ›„์— ํˆฌ์—ฌ. (3) ์ด์ „ ๋‹น๋‡จ๋ฅผ ์ง„๋‹จ๋ฐ›์€ ์‚ฌ๋žŒ์—์„œ ๊ณ ํ˜ˆ๋‹น : ํ‰์ƒ์‹œ์˜ insulin ์šฉ๋Ÿ‰์—์„œ 10% ์ฆ๋Ÿ‰.